Average Co-Inventor Count = 10.87
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (23 from 2,405 patents)
2. Lycera Corporation (5 from 36 patents)
23 patents:
1. 12319671 - 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
2. 12157727 - Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
3. 11498904 - Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
4. 11319283 - Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
5. 11319295 - Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
6. 11208407 - Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
7. 11111232 - Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
8. 11103493 - Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
9. 10995085 - Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
10. 10745364 - Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
11. 10647705 - Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
12. 10538497 - Compounds as indoleamine 2,3-dioxygenase inhibitors
13. 10508108 - Tricyclic compounds as inhibitors of mutant IDH enzymes
14. 10442819 - Tricyclic compounds as inhibitors of mutant IDH enzymes
15. 10221142 - Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof